Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Career
    • Practice Management
      • Reimbursement & Coding
      • Legal
      • Operations
    • Awards
    • Certification
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Compensation Reports
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • By the Numbers
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • mTBI Resource Center
    • ACEP.org
    • ACEP Knowledge Quiz
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • Issue Archives
  • Archives
    • Brief19
    • Coding Wizard
    • Images in EM
    • Care Team
    • Quality & Safety
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

The Facts About Abstral (Sublingual Fentanyl) Tablets

By Michele B. Kaufman, PharmD, BCGP | on November 13, 2017 | 3 Comments
Features
Share:  Print-Friendly Version
PHOTO: shutterstock.com
Read a clinical perspective on from fentanyl Howard K. Mell, MD, MPH, CPE, FACEP.

References

  1. Highlights of prescribing information. FDA website. Accessed Oct. 27, 2017.
  2. Fentanyl transmucosal. Epocrates. San Mateo, California: Epocrates Inc. Updated June 27, 2017. Accessed June 27, 2017.
  3. Lexicomp Online. Hudson, Ohio: Lexi-Comp Inc. Updated June 21, 2017. Accessed June 28, 2017.
  4. Abstral prices, coupons and patient assistance programs. Drugs.com website. Accessed Oct. 27, 2017.

Ms. KaufmanDr. Kaufman is a board certified geriatric pharmacist, a pharmacist at New York-Presbyterian Hospital–Lower Manhattan, and a freelance medical writer and editor.

You Might Also Like
  • Do Emergency Physicians Need Yet Another Fentanyl Option?
  • Facts About the Opium Poppy
  • Drug Overdoses from Acetyl Fentanyl Mixed Into Street Drugs On Rise
Explore This Issue
ACEP Now: Vol 36 – No 11 – November 2017

Pages: 1 2 | Single Page

Topics: AddictionCannabisDrug AbuseDrug UseEducationEmergency DepartmentEmergency MedicineEmergency PhysiciansFentanylMarijuanaMedicalOpioidsPain & Palliative CarePatient CarePublic HealthResearch

Related

  • Full Circle: The Power of Long-Term Mentorship in Emergency Medicine

    February 10, 2026 - 0 Comment
  • Alcohol Use Disorder: Screening Tools and Medications in the ED

    February 10, 2026 - 0 Comment
  • February 2026 News from the College

    January 27, 2026 - 0 Comment

Current Issue

ACEP Now: February 2026 (Digital)

Read More

3 Responses to “The Facts About Abstral (Sublingual Fentanyl) Tablets”

  1. February 20, 2020

    Grant Edmead Reply

    What amount of abstral tablets would be fatal?

  2. July 18, 2020

    larrybenjamin Reply

    thanks very much for the information

  3. July 20, 2025

    Kathy Reply

    Hey there! I was just reading up on Abstral sublingual fentanyl tablets and found some really interesting facts over at acepnow.com. It got me wondering, given the details on the drug at pillintrip.com/medicine/abstral-buccal-sublingual, what are the key differences in how the buccal and sublingual forms of Abstral deliver fentanyl, and does that significantly impact their use for breakthrough cancer pain?

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*



Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603